Oxford Vacmedix UK Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
First-in-human Study of OVM-200 As a Therapeutic Cancer Vaccine
Phase 1
Recruiting
- Conditions
- Non Small Cell Lung CancerProstate CancerOvarian Cancer
- Interventions
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Oxford Vacmedix UK Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT05104515
- Locations
- 🇬🇧
University College London Hospitals NHS Foundation Trust, London, United Kingdom
🇬🇧Sarah Cannon Research Institute UK, London, United Kingdom
🇬🇧The Christie NHS Foundation Trust, Manchester, United Kingdom